State of Wyoming’s UroGen Pharma URGN Stock Holding History

State of Wyoming’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.5K	Buy	+530	New	+$14.4K	﹤0.01%	1801
2025 Q4	–	Sell	-3,301	Closed	-$65.9K	–	2103
2025 Q3	$65.9K	Buy	+3,301	New	+$59.3K	0.01%	1450
2023 Q4	–	Sell	-2,048	Closed	-$28.7K	–	1823
2023 Q3	$28.7K	Buy	+2,048	New	+$32.9K	0.01%	1444
2022 Q2	–	Sell	-337	Closed	-$3K	–	2146
2022 Q1	$3K	Buy	337 +5	+2%	+$39	﹤0.01%	1692
2021 Q4	$3K	Sell	332 -27	-8%	-$381	﹤0.01%	1758
2021 Q3	$6K	Buy	359 +293	+444%	+$4.64K	﹤0.01%	1077
2021 Q2	$1K	Buy	+66	New	+$1.19K	﹤0.01%	1145

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State of Wyoming's URGN Position: Q2 2026 in Review

State of Wyoming opened a new position in UroGen Pharma (URGN) in Q2 2026: 530 shares worth $19.5K. The stake represents ﹤0.01% of the portfolio and ranks #1801 among its holdings. This is a return to the name: State of Wyoming previously reported a position in URGN as recently as Q3 2025.

State of Wyoming first reported a position in URGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $65.9K in Q3 2025. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

State of Wyoming held 530 shares of UroGen Pharma worth $19.5K as of Q2 2026.
UroGen Pharma was a new State of Wyoming position in Q2 2026.
UroGen Pharma made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1801 holding.
State of Wyoming first reported a position in UroGen Pharma in Q2 2021 and has held it in 7 quarters since.
State of Wyoming's UroGen Pharma position peaked at $65.9K in Q3 2025.
189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.